BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y, Huang C. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther 2020;5:113. [PMID: 32616710 DOI: 10.1038/s41392-020-00213-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 29.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Roy S, Wang C, Goel A. A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer. Pharmaceuticals 2022;15:262. [DOI: 10.3390/ph15030262] [Reference Citation Analysis]
2 Kim IS, Hwang CW, Yang WS, Kim CH. Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang. Int J Mol Sci 2021;22:5746. [PMID: 34072216 DOI: 10.3390/ijms22115746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Nipate AS, Jadhav CK, Chate AV, Deshmukh TR, Sarkate AP, Gill CH. Synthesis and In Vitro Anticancer Activities of New 1,4‐Disubstituted‐1,2,3‐triazoles Derivatives through Click Approach. ChemistrySelect 2021;6:5173-9. [DOI: 10.1002/slct.202101035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Choi HS, Ko YS, Jin H, Kang KM, Ha IB, Jeong H, Song HN, Kim HJ, Jeong BK. Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro. Molecules 2021;26:5118. [PMID: 34500557 DOI: 10.3390/molecules26175118] [Reference Citation Analysis]
5 Conti G, Pitea M, Ossanna R, Opri R, Tisci G, Falvo E, Innamorati G, Ghanem E, Sbarbati A, Ceci P, Fracasso G. Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model. Biomedicines 2021;9:1622. [PMID: 34829851 DOI: 10.3390/biomedicines9111622] [Reference Citation Analysis]
6 Timilsina S, Rajamanickam S, Rao A, Subbarayalu P, Nirzhor S, Abdelfattah N, Viswanadhapalli S, Chen Y, Jatoi I, Brenner A, Rao MK, Vadlamudi R, Kaklamani V. The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events. Cancer Lett 2022;540:215717. [PMID: 35568265 DOI: 10.1016/j.canlet.2022.215717] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jarak I, Pereira-silva M, Santos AC, Veiga F, Cabral H, Figueiras A. Multifunctional polymeric micelle-based nucleic acid delivery: Current advances and future perspectives. Applied Materials Today 2021;25:101217. [DOI: 10.1016/j.apmt.2021.101217] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chiu CF, Fu RH, Hsu SH, Yu YA, Yang SF, Tsao TC, Chang KB, Yeh CA, Tang CM, Huang SC, Hung HS. Delivery Capacity and Anticancer Ability of the Berberine-Loaded Gold Nanoparticles to Promote the Apoptosis Effect in Breast Cancer. Cancers (Basel) 2021;13:5317. [PMID: 34771481 DOI: 10.3390/cancers13215317] [Reference Citation Analysis]
9 Dupont CA, Riegel K, Pompaiah M, Juhl H, Rajalingam K. Druggable genome and precision medicine in cancer: current challenges. FEBS J 2021. [PMID: 33626231 DOI: 10.1111/febs.15788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hartung M, Anastasi E, Mamdouh ZM, Nogales C, Schmidt HHHW, Baumbach J, Zolotareva O, List M. Cancer driver drug interaction explorer. Nucleic Acids Res 2022:gkac384. [PMID: 35580047 DOI: 10.1093/nar/gkac384] [Reference Citation Analysis]
11 Bhandari V, Suresh A. Next-Generation Approaches Needed to Tackle Antimicrobial Resistance for the Development of Novel Therapies Against the Deadly Pathogens. Front Pharmacol 2022;13:838092. [PMID: 35721221 DOI: 10.3389/fphar.2022.838092] [Reference Citation Analysis]
12 Zhong W, Wong KH, Xu F, Zhao N, Chen M. NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy. Acta Biomater 2022;145:135-45. [PMID: 35381398 DOI: 10.1016/j.actbio.2022.03.051] [Reference Citation Analysis]
13 Vivarelli S, Candido S, Caruso G, Falzone L, Libra M. Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment. Cancers (Basel) 2020;12:E3636. [PMID: 33291603 DOI: 10.3390/cancers12123636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Zhang W, Zhou L, Qin S, Jiang J, Huang Z, Zhang Z, Zhang X, Shi Z, Lin J. Sertaconazole provokes proapoptotic autophagy via stabilizing TRADD in nonsmall cell lung cancer cells. MedComm (2020) 2021;2:821-37. [PMID: 34977879 DOI: 10.1002/mco2.102] [Reference Citation Analysis]
15 Jafari Nivlouei S, Soltani M, Shirani E, Salimpour MR, Travasso R, Carvalho J. A multiscale cell-based model of tumor growth for chemotherapy assessment and tumor-targeted therapy through a 3D computational approach. Cell Prolif 2022;:e13187. [PMID: 35132721 DOI: 10.1111/cpr.13187] [Reference Citation Analysis]
16 Lin H, Zhou Y, Wang J, Wang H, Yao T, Chen H, Zheng H, Zhang Y, Ren E, Jiang L, Chu C, Chen X, Mao J, Wang F, Liu G. Repurposing ICG enables MR/PA imaging signal amplification and iron depletion for iron-overload disorders. Sci Adv 2021;7:eabl5862. [PMID: 34919434 DOI: 10.1126/sciadv.abl5862] [Reference Citation Analysis]
17 Marshall LJ, Triunfol M, Seidle T. Patient-Derived Xenograft vs. Organoids: A Preliminary Analysis of Cancer Research Output, Funding and Human Health Impact in 2014-2019. Animals (Basel) 2020;10:E1923. [PMID: 33092060 DOI: 10.3390/ani10101923] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Mani S, Swargiary G, Ralph SJ. Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy. Mitochondrion 2021;62:50-73. [PMID: 34758363 DOI: 10.1016/j.mito.2021.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Tsakaneli A, Williams O. Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)-Gene Rearrangements. Front Pharmacol 2021;12:741413. [PMID: 34594227 DOI: 10.3389/fphar.2021.741413] [Reference Citation Analysis]
20 Tang Y, Chen Y, Zhang Z, Tang B, Zhou Z, Chen H. Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective. Pharmaceutics 2021;13:2116. [PMID: 34959397 DOI: 10.3390/pharmaceutics13122116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
21 Huo S, Liao Z, Zhao P, Zhou Y, Göstl R, Herrmann A. Mechano-Nanoswitches for Ultrasound-Controlled Drug Activation. Adv Sci (Weinh) 2022;9:e2104696. [PMID: 35195372 DOI: 10.1002/advs.202104696] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hur S, Jang E, Lee JH. Beneficial Actions of Orostachys japonica and Its Compounds against Tumors via MAPK Signaling Pathways. Nutrients 2021;13:555. [PMID: 33567572 DOI: 10.3390/nu13020555] [Reference Citation Analysis]
23 Zhao H, Li Y. Cancer metabolism and intervention therapy. Mol Biomed 2021;2:5. [PMID: 35006438 DOI: 10.1186/s43556-020-00012-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ronaldson-Bouchard K, Baldassarri I, Tavakol DN, Graney PL, Samaritano M, Cimetta E, Vunjak-Novakovic G. Engineering complexity in human tissue models of cancer. Adv Drug Deliv Rev 2022;184:114181. [PMID: 35278521 DOI: 10.1016/j.addr.2022.114181] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Qorri B, Mokhtari RB, Harless WW, Szewczuk MR. Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression. Cancers (Basel) 2022;14:1374. [PMID: 35326525 DOI: 10.3390/cancers14061374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Maruca A, Rocca R, Catalano R, Mesiti F, Costa G, Lanzillotta D, Salatino A, Ortuso F, Trapasso F, Alcaro S, Artese A. Natural Products Extracted from Fungal Species as New Potential Anti-Cancer Drugs: A Structure-Based Drug Repurposing Approach Targeting HDAC7. Molecules 2020;25:E5524. [PMID: 33255661 DOI: 10.3390/molecules25235524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Talat A, Bashir Y, Khan AU. Repurposing of Antibiotics: Sense or Non-sense. Front Pharmacol 2022;13:833005. [DOI: 10.3389/fphar.2022.833005] [Reference Citation Analysis]
28 Li L, Xiao Y, Xu Z, Wang S. Zileuton inhibits arachidonate-5-lipoxygenase to exert antitumor effects in preclinical cervical cancer models. Cancer Chemother Pharmacol 2021;88:953-60. [PMID: 34477945 DOI: 10.1007/s00280-021-04343-w] [Reference Citation Analysis]
29 Nargeh H, Aliabadi F, Ajami M, Pazoki-Toroudi H. Role of Polyphenols on Gut Microbiota and the Ubiquitin-Proteasome System in Neurodegenerative Diseases. J Agric Food Chem 2021;69:6119-44. [PMID: 34038102 DOI: 10.1021/acs.jafc.1c00923] [Reference Citation Analysis]
30 Islam S, Wang S, Bowden N, Martin J, Head R. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target. Br J Clin Pharmacol 2021. [PMID: 34192364 DOI: 10.1111/bcp.14964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Diwan D, Cheng L, Usmani Z, Sharma M, Holden N, Willoughby N, Sangwan N, Baadhe RR, Liu C, Gupta VK. Microbial cancer therapeutics: A promising approach. Semin Cancer Biol 2021:S1044-579X(21)00131-0. [PMID: 33979677 DOI: 10.1016/j.semcancer.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Loos JA, Coccimiglio M, Nicolao MC, Rodrigues CR, Cumino AC. Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis. Parasitology. [DOI: 10.1017/s0031182021001633] [Reference Citation Analysis]
33 Amiri Souri E, Laddach R, Karagiannis SN, Papageorgiou LG, Tsoka S. Novel drug-target interactions via link prediction and network embedding. BMC Bioinformatics 2022;23:121. [PMID: 35379165 DOI: 10.1186/s12859-022-04650-w] [Reference Citation Analysis]
34 Li PJ, Roose JP, Jablons DM, Kratz JR. Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models. Cancers (Basel) 2021;13:701. [PMID: 33572297 DOI: 10.3390/cancers13040701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Morgen M, Fabrowski P, Amtmann E, Gunkel N, Miller AK. Inclusion Complexes of Gold(I)-Dithiocarbamates with β-Cyclodextrin: A Journey from Drug Repurposing towards Drug Discovery. Chemistry 2021;27:12156-65. [PMID: 34114261 DOI: 10.1002/chem.202101366] [Reference Citation Analysis]
36 Tilija Pun N, Lee N, Song SH, Jeong CH. Pitavastatin Induces Cancer Cell Apoptosis by Blocking Autophagy Flux. Front Pharmacol 2022;13:854506. [PMID: 35387352 DOI: 10.3389/fphar.2022.854506] [Reference Citation Analysis]
37 Poonacha KNT, Villa TG, Notario V. The Interplay among Radiation Therapy, Antibiotics and the Microbiota: Impact on Cancer Treatment Outcomes. Antibiotics 2022;11:331. [DOI: 10.3390/antibiotics11030331] [Reference Citation Analysis]
38 Li Y, Zhao E, Li L, Bai L, Zhang W. Facile design of lidocaine-loaded polymeric hydrogel to persuade effects of local anesthesia drug delivery system: complete in vitro and in vivo toxicity analyses. Drug Deliv 2021;28:1080-92. [PMID: 34114924 DOI: 10.1080/10717544.2021.1931558] [Reference Citation Analysis]
39 Fusciello M, Ylösmäki E, Feola S, Uoti A, Martins B, Aalto K, Hamdan F, Chiaro J, Russo S, Viitala T, Cerullo V. A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella. Mol Ther Oncolytics 2022;25:137-45. [PMID: 35572195 DOI: 10.1016/j.omto.2022.04.002] [Reference Citation Analysis]
40 Cirillo D, Núñez-Carpintero I, Valencia A. Artificial intelligence in cancer research: learning at different levels of data granularity. Mol Oncol 2021;15:817-29. [PMID: 33533192 DOI: 10.1002/1878-0261.12920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 El Zarif T, Yibirin M, De Oliveira-Gomes D, Machaalani M, Nawfal R, Bittar G, Bahmad HF, Bitar N. Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing. Cancers (Basel) 2022;14:2105. [PMID: 35565237 DOI: 10.3390/cancers14092105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Zauner R, Wimmer M, Dorfer S, Ablinger M, Koller U, Piñón Hofbauer J, Guttmann-Gruber C, Bauer JW, Wally V. Transcriptome-Guided Drug Repurposing for Aggressive SCCs. Int J Mol Sci 2022;23:1007. [PMID: 35055192 DOI: 10.3390/ijms23021007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Tabish TA, Hamblin MR. Mitochondria-targeted nanoparticles (mitoNANO): An emerging therapeutic shortcut for cancer. Biomaterials and Biosystems 2021;3:100023. [DOI: 10.1016/j.bbiosy.2021.100023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
44 Li C, Zhang K, Pan G, Ji H, Li C, Wang X, Hu X, Liu R, Deng L, Wang Y, Yang L, Cui H. Dehydrodiisoeugenol inhibits colorectal cancer growth by endoplasmic reticulum stress-induced autophagic pathways. J Exp Clin Cancer Res 2021;40:125. [PMID: 33838688 DOI: 10.1186/s13046-021-01915-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Martinez-Escobar A, Luna-Callejas B, Ramón-Gallegos E. CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research. Front Oncol 2020;10:604948. [PMID: 33614489 DOI: 10.3389/fonc.2020.604948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Kilmister EJ, Tan ST. Insights Into Vascular Anomalies, Cancer, and Fibroproliferative Conditions: The Role of Stem Cells and the Renin-Angiotensin System. Front Surg 2022;9:868187. [DOI: 10.3389/fsurg.2022.868187] [Reference Citation Analysis]
47 Mishra CB, Mongre RK, Prakash A, Jeon R, Supuran CT, Lee MS. Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in vitro and in vivo studies. J Enzyme Inhib Med Chem 2021;36:954-63. [PMID: 33947294 DOI: 10.1080/14756366.2021.1909580] [Reference Citation Analysis]
48 Shoari A, Tooyserkani R, Tahmasebi M, Löwik DWPM. Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade. Pharmaceutics 2021;13:1391. [PMID: 34575464 DOI: 10.3390/pharmaceutics13091391] [Reference Citation Analysis]
49 De Lellis L, Veschi S, Tinari N, Mokini Z, Carradori S, Brocco D, Florio R, Grassadonia A, Cama A. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. Cancers (Basel) 2021;13:3946. [PMID: 34439102 DOI: 10.3390/cancers13163946] [Reference Citation Analysis]
50 Nussinov R, Zhang M, Maloney R, Tsai CJ, Yavuz BR, Tuncbag N, Jang H. Mechanism of activation and the rewired network: New drug design concepts. Med Res Rev 2021. [PMID: 34693559 DOI: 10.1002/med.21863] [Reference Citation Analysis]
51 Španko M, Strnadová K, Pavlíček AJ, Szabo P, Kodet O, Valach J, Dvořánková B, Smetana K Jr, Lacina L. IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives. Int J Mol Sci 2021;22:11027. [PMID: 34681685 DOI: 10.3390/ijms222011027] [Reference Citation Analysis]
52 Yang M, Zhang Z, Nice EC, Wang C, Zhang W, Huang C. Psychological intervention to treat distress: An emerging frontier in cancer prevention and therapy. Biochim Biophys Acta Rev Cancer 2021;1877:188665. [PMID: 34896258 DOI: 10.1016/j.bbcan.2021.188665] [Reference Citation Analysis]
53 Pogacar Z, Groot K, Jochems F, Dos Santos Dias M, Mulero-Sánchez A, Morris B, Roosen M, Wardak L, De Conti G, Velds A, Lieftink C, Thijssen B, Beijersbergen RL, Bernards R, Leite de Oliveira R. Genetic and compound screens uncover factors modulating cancer cell response to indisulam. Life Sci Alliance 2022;5:e202101348. [PMID: 35534224 DOI: 10.26508/lsa.202101348] [Reference Citation Analysis]
54 Sedmidubská B, Luxford TFM, Kočišek J. Electron attachment to isolated and microhydrated favipiravir. Phys Chem Chem Phys 2021. [PMID: 34382983 DOI: 10.1039/d1cp02686k] [Reference Citation Analysis]
55 Tilija Pun N, Jeong CH. Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance. Pharmaceuticals (Basel) 2021;14:470. [PMID: 34065757 DOI: 10.3390/ph14050470] [Reference Citation Analysis]
56 Martin RJ, Robertson AP, Choudhary S. Ivermectin: An Anthelmintic, an Insecticide, and Much More. Trends Parasitol 2021;37:48-64. [PMID: 33189582 DOI: 10.1016/j.pt.2020.10.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
57 Hein MJA, Kvansakul M, Lay FT, Phan TK, Hulett MD. Defensin-lipid interactions in membrane targeting: mechanisms of action and opportunities for the development of antimicrobial and anticancer therapeutics. Biochem Soc Trans 2022:BST20200884. [PMID: 35015081 DOI: 10.1042/BST20200884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Xue B, Zhao B, Luo S, Wu G, Hui X. Inducing apoptosis in human hepatocellular carcinoma cell lines via Nrf2/HO-1 signalling pathway of blueberry and blackcurrant powder manipulated oat bran paste extracts. Journal of Functional Foods 2022;89:104967. [DOI: 10.1016/j.jff.2022.104967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Ding L, Chen Q, Chen K, Jiang Y, Li G, Chen Q, Bai D, Gao D, Deng M, Zhang H, Xu B. Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation. Eur J Pharmacol 2021;913:174633. [PMID: 34843676 DOI: 10.1016/j.ejphar.2021.174633] [Reference Citation Analysis]
60 Jaragh-alhadad LA, Ali MS. Methoxybenzamide derivative of nimesulide from anti-fever to anti-cancer: chemical characterization and cytotoxicity. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Varghese R, Salvi S, Sood P, Kulkarni B, Kumar D. Cubosomes in cancer drug delivery: A review. Colloid and Interface Science Communications 2022;46:100561. [DOI: 10.1016/j.colcom.2021.100561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Ibrahim A, Khalil IA, El-Sherbiny IM. Development and evaluation of core-shell nanocarrier system for enhancing the cytotoxicity of doxorubicin/ metformin combination against breast cancer cell line. J Pharm Sci 2022:S0022-3549(22)00213-1. [PMID: 35613685 DOI: 10.1016/j.xphs.2022.05.018] [Reference Citation Analysis]
63 Lu Y, Pan Q, Gao W, Pu Y, Luo K, He B, Gu Z. Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens. Biomaterials 2021;281:121335. [PMID: 34979419 DOI: 10.1016/j.biomaterials.2021.121335] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
64 Hammoud H, Saker Z, Harati H, Fares Y, Bahmad HF, Nabha S. Drug Repurposing in Medulloblastoma: Challenges and Recommendations. Curr Treat Options Oncol 2020;22:6. [PMID: 33245404 DOI: 10.1007/s11864-020-00805-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ye G, Li J, Zhang J, Liu H, Ye Q, Wang Z. Structural characterization and antitumor activity of a polysaccharide from Dendrobium wardianum. Carbohydr Polym 2021;269:118253. [PMID: 34294290 DOI: 10.1016/j.carbpol.2021.118253] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Kaushal JB, Bhatia R, Kanchan RK, Raut P, Mallapragada S, Ly QP, Batra SK, Rachagani S. Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β. Cancers (Basel) 2021;13:3105. [PMID: 34206370 DOI: 10.3390/cancers13133105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Alzeeb G, Corcos L, Le Jossic-Corcos C. [Spheroids to organoids: Solid cancer models for anticancer drug discovery]. Bull Cancer 2021:S0007-4551(21)00443-4. [PMID: 34848046 DOI: 10.1016/j.bulcan.2021.09.019] [Reference Citation Analysis]
68 Carlos-Escalante JA, de Jesús-Sánchez M, Rivas-Castro A, Pichardo-Rojas PS, Arce C, Wegman-Ostrosky T. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer. Front Oncol 2021;11:660943. [PMID: 34094953 DOI: 10.3389/fonc.2021.660943] [Reference Citation Analysis]
69 García-aranda M, Téllez T, Mckenna L, Redondo M. Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance. Cancers 2022;14:2255. [DOI: 10.3390/cancers14092255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Nelson VK, Sahoo NK, Sahu M, Sudhan HH, Pullaiah CP, Muralikrishna KS. In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116. BMC Complement Med Ther 2020;20:355. [PMID: 33225921 DOI: 10.1186/s12906-020-03118-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
71 Rebelo R, Polónia B, Santos LL, Vasconcelos MH, Xavier CPR. Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals (Basel) 2021;14:280. [PMID: 33804613 DOI: 10.3390/ph14030280] [Reference Citation Analysis]
72 Carafa V, Altucci L. Deregulation of Cell Death in Cancer: Recent Highlights. Cancers (Basel) 2020;12:E3517. [PMID: 33255936 DOI: 10.3390/cancers12123517] [Reference Citation Analysis]
73 Vishnu WK, Abeesh P, Guruvayoorappan C. Pyrazole (1, 2-diazole) induce apoptosis in lymphoma cells by targeting BCL-2 and BCL-XL genes and mitigate murine solid tumour development by regulating cyclin-D1 and Ki-67 expression. Toxicol Appl Pharmacol 2021;418:115491. [PMID: 33737021 DOI: 10.1016/j.taap.2021.115491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Caparica R, Bruzzone M, Agostinetto E, De Angelis C, Fêde Â, Ceppi M, de Azambuja E. Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis. ESMO Open 2021;6:100066. [PMID: 33639601 DOI: 10.1016/j.esmoop.2021.100066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Rausch M, Rutz A, Allard PM, Delucinge-Vivier C, Docquier M, Dormond O, Dyson PJ, Wolfender JL, Nowak-Sliwinska P. Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma. Cancers (Basel) 2021;13:3978. [PMID: 34439134 DOI: 10.3390/cancers13163978] [Reference Citation Analysis]
76 Thomas LW, Ashcroft M. The Contextual Essentiality of Mitochondrial Genes in Cancer. Front Cell Dev Biol 2021;9:695351. [PMID: 34746119 DOI: 10.3389/fcell.2021.695351] [Reference Citation Analysis]
77 Zhang Z, Shi J, Nice EC, Huang C, Shi Z. The Multifaceted Role of Flavonoids in Cancer Therapy: Leveraging Autophagy with a Double-Edged Sword. Antioxidants (Basel) 2021;10:1138. [PMID: 34356371 DOI: 10.3390/antiox10071138] [Reference Citation Analysis]
78 Barman M, Kamble S, Roy S, Bhandari V, Singothu S, Dandasena D, Suresh A, Sharma P. Antitheilerial Activity of the Anticancer Histone Deacetylase Inhibitors. Front Microbiol 2021;12:759817. [PMID: 34867888 DOI: 10.3389/fmicb.2021.759817] [Reference Citation Analysis]
79 Lianos GD, Alexiou GA, Rausei S, Galani V, Mitsis M, Kyritsis AP. Repurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives. Expert Rev Anticancer Ther 2021;:1-4. [PMID: 34612130 DOI: 10.1080/14737140.2022.1987221] [Reference Citation Analysis]
80 Turabi KS, Deshmukh A, Paul S, Swami D, Siddiqui S, Kumar U, Naikar S, Devarajan S, Basu S, Paul MK, Aich J. Drug repurposing-an emerging strategy in cancer therapeutics. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 35695911 DOI: 10.1007/s00210-022-02263-x] [Reference Citation Analysis]
81 Ghosalkar J, Sonawane V, Pisal T, Achrekar S, Pujari R, Chugh A, Shastry P, Joshi K. Prostate Apoptosis Response-4 (Par-4): A Novel Target in Pyronaridine-Induced Apoptosis in Glioblastoma (GBM) Cells. Cancers 2022;14:3198. [DOI: 10.3390/cancers14133198] [Reference Citation Analysis]
82 Li Z, Ma J, Kuang Z, Jiang Y. β-Asarone Attenuates Aβ-Induced Neuronal Damage in PC12 Cells Overexpressing APPswe by Restoring Autophagic Flux. Front Pharmacol 2021;12:701635. [PMID: 34393783 DOI: 10.3389/fphar.2021.701635] [Reference Citation Analysis]
83 Pal D, Song IH, Dashrath Warkad S, Song KS, Seong Yeom G, Saha S, Shinde PB, Balasaheb Nimse S. Indazole-based microtubule-targeting agents as potential candidates for anticancer drugs discovery. Bioorg Chem 2022;122:105735. [PMID: 35298962 DOI: 10.1016/j.bioorg.2022.105735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Zhang H, Zhang Z, Huang Y, Qin S, Zhou L, Weng N, Liu J, Yang M, Zhang X, Lu Y, Ma L, Zheng S, Li Q. Repurposing antitussive benproperine phosphate against pancreatic cancer depends on autophagy arrest. Mol Oncol 2021;15:725-38. [PMID: 33226737 DOI: 10.1002/1878-0261.12854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Barra J, Cerda-Infante J, Sandoval L, Gajardo-Meneses P, Henriquez JF, Labarca M, Metz C, Venegas J, Retamal C, Oyanadel C, Cancino J, Soza A, Cuello MA, Roa JC, Montecinos VP, Gonzalez A. D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy. Cancers (Basel) 2021;13:3622. [PMID: 34298835 DOI: 10.3390/cancers13143622] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Pan X, Lin X, Cao D, Zeng X, Yu PS, He L, Nussinov R, Cheng F. Deep learning for drug repurposing: Methods, databases, and applications. WIREs Comput Mol Sci 2022;12. [DOI: 10.1002/wcms.1597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Kumbhar P, Manjappa A, Shah R, Jha NK, Singh SK, Dua K, Disouza J, Patravale V. Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges. J Control Release 2021;341:1-15. [PMID: 34780880 DOI: 10.1016/j.jconrel.2021.11.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Zhukova OV, Kovaleva TF, Arkhipova EV, Ryabov SA, Mukhina IV. Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review). Biomed Rep 2020;13:47. [PMID: 32934819 DOI: 10.3892/br.2020.1354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Grobs Y, Awada C, Lemay SE, Romanet C, Bourgeois A, Toro V, Nadeau V, Shimauchi K, Orcholski M, Breuils-Bonnet S, Tremblay E, Provencher S, Paulin R, Boucherat O, Bonnet S. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension. Int J Mol Sci 2021;22:2919. [PMID: 33805714 DOI: 10.3390/ijms22062919] [Reference Citation Analysis]
90 Kumbhar P, Kole K, Yadav T, Bhavar A, Waghmare P, Bhokare R, Manjappa A, Jha NK, Chellappan DK, Shinde S, Singh SK, Dua K, Salawi A, Disouza J, Patravale V. Drug repurposing: An emerging strategy in alleviating skin cancer. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175031] [Reference Citation Analysis]
91 Li C, Yao H, Wang H, Fang JY, Xu J. Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity. Oncogene 2021;40:1128-46. [PMID: 33323966 DOI: 10.1038/s41388-020-01592-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
92 Antona A, Varalda M, Roy K, Favero F, Mazzucco E, Zuccalà M, Leo G, Soggia G, Bettio V, Tosi M, Gaggianesi M, Riva B, Reano S, Genazzani A, Manfredi M, Stassi G, Corà D, D'Alfonso S, Capello D. Dissecting the Mechanism of Action of Spiperone-A Candidate for Drug Repurposing for Colorectal Cancer. Cancers (Basel) 2022;14:776. [PMID: 35159043 DOI: 10.3390/cancers14030776] [Reference Citation Analysis]
93 Ramchandani S, Mohan CD, Mistry JR, Su Q, Naz I, Rangappa KS, Ahn KS. The multifaceted antineoplastic role of pyrimethamine against different human malignancies. IUBMB Life 2021. [PMID: 34921584 DOI: 10.1002/iub.2590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
94 Goenka L, Ganesan P. Drug Repurposing in Oncology. Indian J Med Paediatr Oncol 2021;42:194-8. [DOI: 10.1055/s-0041-1733825] [Reference Citation Analysis]
95 Weng N, Qin S, Liu J, Huang X, Jiang J, Zhou L, Zhang Z, Xie N, Wang K, Jin P, Luo M, Peng L, Nice EC, Goel A, Han S, Huang C, Zhu Q. Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.01.018] [Reference Citation Analysis]
96 Mokou M, Lygirou V, Angelioudaki I, Paschalidis N, Stroggilos R, Frantzi M, Latosinska A, Bamias A, Hoffmann MJ, Mischak H, Vlahou A. A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures. Cancers (Basel) 2020;12:E3519. [PMID: 33255925 DOI: 10.3390/cancers12123519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
97 Zhang Z, Qin S, Chen Y, Zhou L, Yang M, Tang Y, Zuo J, Zhang J, Mizokami A, Nice EC, Chen HN, Huang C, Wei X. Inhibition of NPC1L1 disrupts adaptive responses of drug-tolerant persister cells to chemotherapy. EMBO Mol Med 2022;:e14903. [PMID: 35023619 DOI: 10.15252/emmm.202114903] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
98 Di Sotto A, Mancinelli R, Gullì M, Eufemi M, Mammola CL, Mazzanti G, Di Giacomo S. Chemopreventive Potential of Caryophyllane Sesquiterpenes: An Overview of Preliminary Evidence. Cancers (Basel) 2020;12:E3034. [PMID: 33081075 DOI: 10.3390/cancers12103034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
99 Chen MY, Yadav VK, Chu YC, Ong JR, Huang TY, Lee KF, Lee KH, Yeh CT, Lee WH. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers (Basel) 2021;13:3227. [PMID: 34203465 DOI: 10.3390/cancers13133227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Tilaoui M, Ait Mouse H, Zyad A. Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids. Front Pharmacol 2021;12:719694. [PMID: 34975465 DOI: 10.3389/fphar.2021.719694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Parvathaneni V, Elbatanony RS, Goyal M, Chavan T, Vega N, Kolluru S, Muth A, Gupta V, Kunda NK. Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes. Int J Mol Sci 2021;22:4783. [PMID: 33946414 DOI: 10.3390/ijms22094783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
102 Jhou AJ, Chang HC, Hung CC, Lin HC, Lee YC, Liu WT, Han KF, Lai YW, Lin MY, Lee CH. Chlorpromazine, an antipsychotic agent, induces G2/M phase arrest and apoptosis via regulation of the PI3K/AKT/mTOR-mediated autophagy pathways in human oral cancer. Biochem Pharmacol 2021;184:114403. [PMID: 33388284 DOI: 10.1016/j.bcp.2020.114403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
103 Naderbar L, Pazhang Y, Rezaie J. Inhibiting AKT signaling pathway with cilostazol and meloxicam synergism for suppressing K562 cells in vitro. J Biochem Mol Toxicol 2022;:e23185. [PMID: 35920412 DOI: 10.1002/jbt.23185] [Reference Citation Analysis]
104 Jain AS, Prasad A, Pradeep S, Dharmashekar C, Achar RR, Ekaterina S, Victor S, Amachawadi RG, Prasad SK, Pruthvish R, Syed A, Shivamallu C, Kollur SP. Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway. Front Oncol 2021;11:741326. [PMID: 34692523 DOI: 10.3389/fonc.2021.741326] [Reference Citation Analysis]
105 Rahman MA, Hannan MA, Dash R, Rahman MH, Islam R, Uddin MJ, Sohag AAM, Rahman MH, Rhim H. Phytochemicals as a Complement to Cancer Chemotherapy: Pharmacological Modulation of the Autophagy-Apoptosis Pathway. Front Pharmacol 2021;12:639628. [PMID: 34025409 DOI: 10.3389/fphar.2021.639628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
106 Kaur J, Gulati M, Kumar Jha N, Disouza J, Patravale V, Dua K, Kumar Singh S. Recent advances in developing polymeric micelles for treating cancer: breakthroughs and bottlenecks in their clinical translation. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
107 Carvalho RF, do Canto LM, Cury SS, Frøstrup Hansen T, Jensen LH, Rogatto SR. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer. Cancers (Basel) 2021;13:5492. [PMID: 34771654 DOI: 10.3390/cancers13215492] [Reference Citation Analysis]
108 Guzev E, Jadhav SS, Hezkiy EE, Sherman MY, Firer MA, Bunimovich-mendrazitsky S. Validation of a Mathematical Model Describing the Dynamics of Chemotherapy for Chronic Lymphocytic Leukemia In Vivo. Cells 2022;11:2325. [DOI: 10.3390/cells11152325] [Reference Citation Analysis]
109 Weiss M, Nikisher B, Haran H, Tefft K, Adams J, Edwards J. High throughput screen of small molecules as potential countermeasures to galactic cosmic radiation induced cellular dysfunction. Life Sciences in Space Research 2022. [DOI: 10.1016/j.lssr.2022.06.006] [Reference Citation Analysis]
110 Malik JA, Ahmed S, Jan B, Bender O, Al Hagbani T, Alqarni A, Anwar S. Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges. Biomed Pharmacother 2022;145:112375. [PMID: 34863612 DOI: 10.1016/j.biopha.2021.112375] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
111 Zong N, Li N, Wen A, Ngo V, Yu Y, Huang M, Chowdhury S, Jiang C, Fu S, Weinshilboum R, Jiang G, Hunter L, Liu H. BETA: a comprehensive benchmark for computational drug-target prediction. Brief Bioinform 2022:bbac199. [PMID: 35649342 DOI: 10.1093/bib/bbac199] [Reference Citation Analysis]
112 Abdelgawad MA, Elkanzi NA, Nayl A, Musa A, Hadal Alotaibi N, Arafa W, Gomha SM, Bakr RB. Targeting tumor cells with pyrazolo[3,4-d]pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.103781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
113 Siddiqui S, Deshmukh AJ, Mudaliar P, Nalawade AJ, Iyer D, Aich J. Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review. J Egypt Natl Canc Inst 2022;34. [DOI: 10.1186/s43046-022-00137-0] [Reference Citation Analysis]
114 Park JH, de Lomana ALG, Marzese DM, Juarez T, Feroze A, Hothi P, Cobbs C, Patel AP, Kesari S, Huang S, Baliga NS. A Systems Approach to Brain Tumor Treatment. Cancers (Basel) 2021;13:3152. [PMID: 34202449 DOI: 10.3390/cancers13133152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Xu P, Zhang S, Tan L, Wang L, Yang Z, Li J. Local Anesthetic Ropivacaine Exhibits Therapeutic Effects in Cancers. Front Oncol 2022;12:836882. [PMID: 35186766 DOI: 10.3389/fonc.2022.836882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Wagner J, Wickman E, DeRenzo C, Gottschalk S. CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality? Mol Ther 2020;28:2320-39. [PMID: 32979309 DOI: 10.1016/j.ymthe.2020.09.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
117 Alqahtani T, Alswied A, Sun D. Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity. Cancers (Basel) 2021;13:3288. [PMID: 34209165 DOI: 10.3390/cancers13133288] [Reference Citation Analysis]
118 Saka-herrán C, Jané-salas E, Mano-azul A, Torrejón-moya A, Estrugo-devesa A, López-lópez J. Effects of the Prior Use of Statins on Head and Neck Cancer Risk: A Hospital-Based Case–Control Study. Pharmaceuticals 2022;15:579. [DOI: 10.3390/ph15050579] [Reference Citation Analysis]
119 Park Y, Heider D, Hauschild AC. Integrative Analysis of Next-Generation Sequencing for Next-Generation Cancer Research toward Artificial Intelligence. Cancers (Basel) 2021;13:3148. [PMID: 34202427 DOI: 10.3390/cancers13133148] [Reference Citation Analysis]
120 Jin P, Jiang J, Zhou L, Huang Z, Nice EC, Huang C, Fu L. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol 2022;15:97. [PMID: 35851420 DOI: 10.1186/s13045-022-01313-4] [Reference Citation Analysis]